{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:33:48Z","timestamp":1790379228234,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11064-010-0346-5","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T00:14:38Z","timestamp":1291248878000},"page":"1933-1938","source":"Crossref","is-referenced-by-count":61,"title":["Vascular Cognitive Disorder. A Biological and Clinical Overview"],"prefix":"10.1007","volume":"35","author":[{"given":"Leontino","family":"Battistin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annachiara","family":"Cagnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,3]]},"reference":[{"key":"346_CR1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.54.1.4","volume":"54","author":"L Fratiglioni","year":"2000","unstructured":"Fratiglioni L, Launer LJ, Andersen K et al (2000) Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 54:S4\u2013S9","journal-title":"Neurology"},{"key":"346_CR2","first-page":"197","volume-title":"Handbook of Neuroepidemiology","author":"PB Gorelick","year":"1994","unstructured":"Gorelick PB, Roman G, Mangone CA (1994) Vascular dementia. In: Gorelick PB, Alter MA (eds) Handbook of Neuroepidemiology. Mecel Dekker, New York, pp 197\u2013214"},{"key":"346_CR3","unstructured":"Binswanger O (1894) Die Abgrenzung der allgemeinen progressiven paralyse. Berl. Klein. Wochenschr. 31:1102\u20131205, 1137\u20131139, 1180\u20131186"},{"key":"346_CR4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(74)91496-2","volume":"2","author":"VC Hachinski","year":"1974","unstructured":"Hachinski VC, Lassen MA, Marshall J (1974) Multi-infarct dementia. A cause of mental deterioration in elderly. Lancet 2:207\u2013210","journal-title":"Lancet"},{"key":"346_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2004.09.016","volume":"226","author":"GC Roman","year":"2004","unstructured":"Roman GC, Sachdev P, Royall DR et al (2004) Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. Neurol Sci 226:81\u201387","journal-title":"Neurol Sci"},{"key":"346_CR6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/(SICI)1099-1166(199905)14:5<402::AID-GPS958>3.0.CO;2-H","volume":"14","author":"P Sachdev","year":"1999","unstructured":"Sachdev P (1999) Vascular cognitive disorder. Int J Geriatr Psychiatry 14:402\u2013403","journal-title":"Int J Geriatr Psychiatry"},{"key":"346_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(03)00305-3","volume":"2","author":"JT O\u2019Brien","year":"2003","unstructured":"O\u2019Brien JT, Erkinjuntti T, Reisberg B et al (2003) Vascular cognitive impairment. Lancet Neurol 2:89\u201398","journal-title":"Lancet Neurol"},{"key":"346_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-0-387-30377-2_14","volume-title":"Handbook of neurochemistry and molecular neurobiology","author":"A Cagnin","year":"2007","unstructured":"Cagnin A, Battistin L (2007) Vascular dementia. In: Readerer Battistin (ed) Handbook of neurochemistry and molecular neurobiology. Springer-Verlag, Berlin-Eidelberg, pp 253\u2013265"},{"key":"346_CR9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.42.3.473","volume":"42","author":"HC Chui","year":"1992","unstructured":"Chui HC, Victoroff JI, Margolin D et al (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer disease diagnostic and treatment centers (ADDTC). Neurology 42:473\u2013480","journal-title":"Neurology"},{"key":"346_CR10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjutti T et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 43:250\u2013260","journal-title":"Neurology"},{"key":"346_CR11","volume-title":"International classification of diseases. Tenth Revision","author":"WorldHealth Organization","year":"1993","unstructured":"Organization WorldHealth (1993) International classification of diseases. Tenth Revision. World Health Organization, Geneva"},{"key":"346_CR12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1212\/01.WNL.0000168877.06011.15","volume":"65","author":"CC Price","year":"2005","unstructured":"Price CC, Jefferson AL, Merino JG et al (2005) Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology 65:376\u2013382","journal-title":"Neurology"},{"key":"346_CR13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1212\/WNL.55.4.604-b","volume":"55","author":"DR Royall","year":"2000","unstructured":"Royall DR, Roman GC (2000) Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 55:604\u2013606","journal-title":"Neurology"},{"key":"346_CR14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1212\/01.WNL.0000138435.19761.93","volume":"63","author":"CG Ballard","year":"2004","unstructured":"Ballard CG, Burton EJ, Barber R et al (2004) NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology 63:983\u2013988","journal-title":"Neurology"},{"key":"346_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00401-006-0185-2","volume":"113","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol 113:349\u2013388","journal-title":"Acta Neuropathol"},{"key":"346_CR16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000051248","volume":"12","author":"G Lesser","year":"2001","unstructured":"Lesser G, Kandiah K, Libow LS et al (2001) Elevated serum total and LDL cholesterol in very old patients with Alzheimer\u2019s disease. Dement Geriat Cogn Disord 12:138\u2013145","journal-title":"Dement Geriat Cogn Disord"},{"key":"346_CR17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/WNL.54.1.240","volume":"54","author":"RM Evans","year":"2000","unstructured":"Evans RM, Emsley CL, Gao S et al (2000) Serum cholesterol, APOE genotype, and the risk of Alzheimer\u2019s disease: a population-based study of African Americans. Neurology 54:240\u2013242","journal-title":"Neurology"},{"key":"346_CR18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","volume":"5","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, Ngandu T, Laatikainen T et al (2006) Risk score for the prediction of dementia risk in 20\u00a0years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5:735\u2013741","journal-title":"Lancet Neurol"},{"key":"346_CR19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.66.3.343","volume":"66","author":"EP Helzner","year":"2009","unstructured":"Helzner EP, Luchsinger JA, Scarmeas N et al (2009) Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 66:343\u2013348","journal-title":"Arch Neurol"},{"key":"346_CR20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1212\/WNL.53.3.517","volume":"53","author":"SN Romas","year":"1999","unstructured":"Romas SN, Tang MX, Berglund L et al (1999) APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology 53:517\u2013521","journal-title":"Neurology"},{"key":"346_CR21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archinte.163.9.1053","volume":"163","author":"ZS Tan","year":"2003","unstructured":"Tan ZS, Seshadri S, Beiser A et al (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham study. Arch Int Med 163:1053\u20131057","journal-title":"Arch Int Med"},{"key":"346_CR22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0404.2006.00685.x","volume":"114","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, Solomon A (2006) Cholesterol as a risk factor for Alzheimer\u2019s disease-epidemiological evidence. Acta Neurol Scand 114:50\u201357","journal-title":"Acta Neurol Scand"},{"key":"346_CR23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresrev.2005.11.007","volume":"51","author":"F Panza","year":"2006","unstructured":"Panza F, D\u2019Introno A, Colacicco AM et al (2006) Lipid metabolism in cognitive decline and dementia. Brain Res Rev 51:275\u2013292","journal-title":"Brain Res Rev"},{"key":"346_CR24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neurobiolaging.2007.10.019","volume":"30","author":"F Panza","year":"2009","unstructured":"Panza F, Solfrizzi V, D\u2019Introno A et al (2009) Higher total cholesterol, cognitive decline, and dementia. Neurobiol Aging 30:546\u2013548","journal-title":"Neurobiol Aging"},{"key":"346_CR25","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v66n0720","volume":"66","author":"A Papassotiropoulos","year":"2005","unstructured":"Papassotiropoulos A, Wollmer MA, Tsolaki M et al (2005) A cluster of cholesterol-related genes confers susceptibility for Alzheimer\u2019s disease. J Clin Psychiatry 66:940\u2013947","journal-title":"J Clin Psychiatry"},{"key":"346_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-211-73574-9_22","volume":"72","author":"A Cagnin","year":"2007","unstructured":"Cagnin A, ZAmbon A, Zarantonello G et al (2007) Serum lipoprotein profile and APOE genotype in Alzheimer\u2019s disease. J Neural Transm Suppl 72:175\u2013179","journal-title":"J Neural Transm Suppl"},{"key":"346_CR27","doi-asserted-by":"crossref","unstructured":"Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat Rev Neurosci 5:347\u2013360","DOI":"10.1038\/nrn1387"},{"key":"346_CR28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178\u2013201","journal-title":"Neuron"},{"key":"346_CR29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.STR.0000195177.61184.49","volume":"37","author":"GG Leblanc","year":"2006","unstructured":"Leblanc GG, Meschia JF, Stuss DT et al (2006) Genetics of vascular cognitive impairment. The opportunity and the challenges. Stroke 37:248\u2013255","journal-title":"Stroke"},{"key":"346_CR30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1001\/jama.1997.03540340052032","volume":"277","author":"AJC Slooter","year":"1997","unstructured":"Slooter AJC, Tang M-X, van Duijn CM et al (1997) Apolipoprotein E 4 and the risk of dementia with stroke: a population-based investigation. JAMA 277:818\u2013821","journal-title":"JAMA"},{"key":"346_CR31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1468-1331.1999.640415.x","volume":"6","author":"L Traykov","year":"1999","unstructured":"Traykov L, Rigaud AS, Caputo L et al (1999) Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease. Eur J Neurology 6:415\u2013421","journal-title":"Eur J Neurology"},{"key":"346_CR32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jns.2004.11.031","volume":"229\u2013230","author":"C Briani","year":"2005","unstructured":"Briani C, Cagnin A, Gallo L et al (2005) Anti-heparan sulphate antibodies and homocysteine: markers of vascular pathology? J Neurol Sci 229\u2013230:215\u2013218","journal-title":"J Neurol Sci"},{"key":"346_CR33","first-page":"159","volume":"35","author":"JC Adair","year":"2004","unstructured":"Adair JC, Charlie J, Dencoff JE et al (2004) Measurement of gelatinase B (MMP-9) in cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Brain 35:159\u2013162","journal-title":"Brain"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-010-0346-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-010-0346-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-010-0346-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:36:23Z","timestamp":1559349383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-010-0346-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1007\/s11064-010-0346-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}